Should Heparin Drip Be Paused Prior to I&D?
Yes, heparin infusion should be stopped 4-6 hours before incision and drainage to allow anticoagulant effects to dissipate and minimize bleeding risk.
Timing of Heparin Discontinuation
The evidence consistently supports stopping intravenous unfractionated heparin (UFH) 4-6 hours before surgical procedures, including I&D:
- For therapeutic-dose IV UFH: Stop the infusion ≥4 hours before the procedure 1, 2
- This timing is based on UFH's elimination half-life of approximately 90 minutes (range 30-120 minutes depending on anticoagulation intensity) 1
- The 4-6 hour window allows complete clearance of anticoagulant effect before incision 3
The FDA labeling for heparin specifically advises patients to inform physicians before any surgery is scheduled due to hemorrhage risk 4.
Post-Procedure Resumption
Resume heparin ≥24 hours after the procedure once hemostasis is adequately controlled 1, 2:
- Avoid bolus dosing when restarting
- Use a lower-intensity infusion initially 1
- Can restart "as early after surgery as bleeding stability allows" but generally wait at least 24 hours 3
- Some sources suggest resumption can occur once hemostasis is achieved, typically within 24 hours 2
Risk Stratification Considerations
The decision to hold heparin must balance:
Bleeding Risk: I&D procedures carry moderate bleeding risk due to:
- Incision through potentially infected/inflamed tissue
- Variable vascularity depending on abscess location
- Need for adequate hemostasis to prevent hematoma formation
Thrombotic Risk: For patients on therapeutic heparin, assess their underlying indication:
- High-risk patients (mechanical mitral valve, recent VTE <3 months, history of thromboembolism): The brief 4-6 hour interruption poses minimal thrombotic risk (estimated 0.08-0.16% for 3-day interruption) 3
- Most I&D procedures can be completed within timeframes that don't require bridging strategies
Common Pitfalls to Avoid
Don't continue heparin through the procedure: Unlike minimal-risk procedures (dental cleaning, skin surgery), I&D requires adequate hemostasis and anticoagulation should be interrupted 3
Don't stop too close to procedure time: Stopping <4 hours before surgery leaves residual anticoagulant effect and increases bleeding risk 1
Don't restart too early: Resuming within 24 hours significantly increases postoperative bleeding risk 1
Don't give bolus when restarting: Use lower-intensity infusion to reduce bleeding complications 1
Practical Algorithm
Pre-procedure:
- Stop IV heparin infusion 4-6 hours before scheduled I&D
- No reversal agents needed for elective procedures
- Verify adequate time has elapsed before incision
Intra-procedure:
- Use local hemostatic measures as needed
- Ensure adequate hemostasis before closure
Post-procedure:
- Monitor for bleeding complications
- Resume heparin ≥24 hours post-procedure without bolus
- Use lower initial infusion rate
This approach minimizes bleeding risk while maintaining only a brief interruption in anticoagulation, which poses negligible thrombotic risk for the vast majority of patients requiring I&D procedures.